Targeted Germline Sequencing Identifies Ultra-Rare DDR Variants in High-Risk Prostate Cancer

Rawaz Rizgar Hassan, Abdulkarim Yasin Karim

Open source

DOI
10.31661/gmj.v15i.4248
Published
2026-08-10
Container
Galen Medical Journal
Publisher
Salvia Medical Sciences Ltd
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.31661/gmj.v15i.4248,
  title = {Targeted Germline Sequencing Identifies Ultra-Rare DDR Variants in High-Risk Prostate Cancer},
  author = {Rawaz Rizgar Hassan and Abdulkarim Yasin Karim},
  year = {2026},
  journal = {Galen Medical Journal},
  doi = {10.31661/gmj.v15i.4248},
  url = {https://doi.org/10.31661/gmj.v15i.4248}
}

RIS

TY  - JOUR
TI  - Targeted Germline Sequencing Identifies Ultra-Rare DDR Variants in High-Risk Prostate Cancer
AU  - Rawaz Rizgar Hassan
AU  - Abdulkarim Yasin Karim
PY  - 2026
JO  - Galen Medical Journal
DO  - 10.31661/gmj.v15i.4248
UR  - https://doi.org/10.31661/gmj.v15i.4248
ER  - 

APA

Hassan, R. R., & Karim, A. Y. (2026). Targeted Germline Sequencing Identifies Ultra-Rare DDR Variants in High-Risk Prostate Cancer. Galen Medical Journal. https://doi.org/10.31661/gmj.v15i.4248

Source records